button bars forest bayes pooled summary circles
 
deaths (OS)

mML - L1 - BRAF mutant metastatic/adv melanoma (mML) mML - 1st line (L1) mML - L1 - BRAF mutant

versus ipilimumab alone
nivolumab plus ipilimumab vs. ipilimumab alone 1 1.0better0.35.073 %
versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 1.0better0.35.088 %

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons